03 Aug CASE STUDY: GOOD THERAPEUTICS
This is a case study of RiverVest portfolio company Good Therapeutics, which was acquired by Roche in 2022 for $250 million upfront plus potential milestone returns....
13 Jun The Orphan Drug Act of 1983 by Niall O’Donnell
In this article, Managing Director Niall O’Donnell, Ph.D. discusses the law that transformed orphan drug development and how one actor’s starring role in its passage spurred 40 years of prolific, life-saving innovation. ...
24 Apr CASE STUDY: Standard Bariatrics
This is a case study of RiverVest's role in financing and guiding Cincinnati-based portfolio company Standard Bariatrics through acquisition by Teleflex, Inc....
03 Jan IN THE NEWS / RiverVest’s Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020
JAN 2020RiverVest's Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 3, 2020) St. Louis Business JournalRead the Press ReleasePerhaps no part of the St. Louis economy surged in the past decade more...
- 1
- 2